Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances experimental-treatment bill with licensing, liability and access provisions
Summary
The committee approved Senate Bill 535 as twice amended, adopting changes that remove licensure exemptions, strike broad immunity language, and add a provision requiring licensed experimental-treatment centers to allocate 2% of net profits to patient access or an insurance premium support account administered by DPHHS.
The House Health and Human Services Committee voted to advance Senate Bill 535 after adopting two substantive amendments that alter licensure, liability and access provisions for experimental-treatment centers.
Ms. Allen, committee staff, explained a packet of competing amendments to SB535 and said several resolve a conflict with HB414 over licensure exemptions. One adopted amendment (SB535.2.4) adds a "health freedom and access" requirement: licensed experimental-treatment centers would allocate at least 2% of net annual profits either to provide free experimental treatment to qualifying…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
